Evolva Holding (0QQJ) AI Stock Analysis

Evolva Holding

(LSE:0QQJ)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low Financial LeverageNo debt from 2023–2025 limits interest-bearing obligations and reduces balance-sheet strain. This gives Evolva greater financial flexibility to preserve resources, pursue its ingredient and biotechnology activities, or withstand operating volatility without added lender pressure.

Negative Factors

Zero Recent RevenueRevenue dropping to zero in both 2024 and 2025 indicates that Evolva currently lacks a durable operating revenue base. Without recurring sales, the company has limited evidence of commercial scale, making future profitability and self-funded growth dependent on rebuilding meaningful business activity.

Evolva Holding (0QQJ) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: CHF 15.50M
Dividend Yield: ―
Average Volume (3M): 2,010
Price to Earnings (P/E): -17.7
Beta (1Y): 0.65
Revenue Growth: ―
EPS Growth: -39.83%
Country: UK
Employees: 49
Sector: Financial
Sector Strength: 68
Industry: Shell Companies

Evolva Holding Business Overview & Revenue Model

Company Description

EvoNext Holdings SA is dedicated to the exploration, creation, and distribution of pioneering ingredients across the nutritional, health, and wellness domains. Founded in 2004, the company's inception is attributed to Alexandra Santana Sørensen, Søre...

Evolva Holding Peers Comparison

Overall Rating

UnderperformOutperform

Sector (68)

Financial Indicators

GB:0QQJ against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CH:BANB	80Outperform	CHF 6.30B	42.24	10.27%	1.07%	4.51%	11.05%
Sector *	68Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
CH:LONN	67Neutral	CHF 43.90B	-418.31	―	0.78%	-10.77%	-114.77%
CH:KURN	63Neutral	CHF 820.58M	114.03	10.24%	―	40.91%	―
CH:MOLN	44Neutral	CHF 116.68M	-2.13	-79.25%	―	-100.00%	24.46%

* Financial Sector Average

Performance Comparison

GB:0QQJ and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0QQJ	Evolva Holding Sa	2.21	1.32	147.76%
CH:MOLN	Molecular Partners	2.89	-0.34	-10.66%
CH:LONN	Lonza Group	644.20	110.60	20.73%
CH:BANB	Bachem Holding AG Class B	84.05	30.88	58.09%
CH:KURN	Kuros Biosciences	20.64	-9.48	-31.47%
CH:XLS	Xlife Sciences Ltd.	8.80	-11.20	-56.00%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Evolva Holding AI Stock Analysis